Idealpharma SPRL
The score of Idealpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -79 % Total assets -20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Idealpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −193,427 € | ||||
| Equity | 55,469 € | ||||
| Cash | 7,048 € | ||||
| EBITDA | −131,077 € | ||||
| Total assets | 804,498 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 05 Aug 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Idealpharma's financial analysis
- Solvency6.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Idealpharma
Idealpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0864.605.936
- VAT number
- BE0864605936
- Peppol
- Registered · 0208:0864605936 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 08 Apr 2004
- Registered office
- 2660 Antwerp
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Idealpharma (SPRL) has been based in Antwerp since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 193,427 € and equity of 55,469 €; its revenue is not published. Its solvency stands at 6.9%, below the median of its sector (44.2%).
Companies similar to Idealpharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek I. VAN Pelt Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 813,014 €
- Zoniapharma Retail sale of pharmaceutical products Sint-Genesius-Rode · balance sheet 804,389 €
- Pharmacie Pierre Wagner Retail sale of pharmaceutical products Anthisnes · balance sheet 804,671 €
- Wijmenput Retail sale of pharmaceutical products Aalst · balance sheet 805,856 €
- Geassocieerde Apotheek Dhondt Retail sale of pharmaceutical products Gavere · balance sheet 806,404 €
- Esbe - Pharma Retail sale of pharmaceutical products Châtelet · balance sheet 808,162 €
- AllGor Retail sale of pharmaceutical products Kortrijk · balance sheet 810,045 €
- Pharmachim Retail sale of pharmaceutical products Seraing · balance sheet 797,111 €
Frequently asked questions about Idealpharma
What is the revenue of Idealpharma?
Idealpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Idealpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0864605936 for Idealpharma, if the company is VAT-registered. Its company number (CBE) is 0864.605.936.
Where is the registered office of Idealpharma?
According to the CBE register, the registered office of Idealpharma is in 2660 Antwerp.
What is the equity of Idealpharma?
At the close of the 2025 financial year, the equity of Idealpharma amounts to 55,469 €, a solvency of 6.9% of total assets.
Who manages Idealpharma?
The register lists 2 active mandates at Idealpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Idealpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →